These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 15580246)
1. Creating incentives for genomic research to improve targeting of therapies. Evans BJ; Flockhart DA; Meslin EM Nat Med; 2004 Dec; 10(12):1289-91. PubMed ID: 15580246 [No Abstract] [Full Text] [Related]
2. Genomic sciences and the medicine of tomorrow. Drews J Nat Biotechnol; 1996 Nov; 14(11):1516-8. PubMed ID: 9634812 [No Abstract] [Full Text] [Related]
4. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification. Smart A; Martin P Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196 [TBL] [Abstract][Full Text] [Related]
5. [The future of pharmacogenetics--cost-effectiveness and barriers]. Gyrd-Hansen D Ugeskr Laeger; 2005 May; 167(20):2153-5. PubMed ID: 15987071 [No Abstract] [Full Text] [Related]
6. Biotech drugs come of age; policymakers take notice. Iglehart JK Health Aff (Millwood); 2006; 25(5):1202-3. PubMed ID: 16966714 [No Abstract] [Full Text] [Related]
7. Pharmacogenetics--where are we and where are we heading? Kola I Pharmacogenomics; 2005 Dec; 6(8):793-5. PubMed ID: 16296941 [No Abstract] [Full Text] [Related]
8. Drug companies accused of stalling tailored therapies. Sinha G Nat Med; 2006 Sep; 12(9):983. PubMed ID: 16960561 [No Abstract] [Full Text] [Related]
9. The DNA Rx. Advances in genetics give physicians ability to tailor drugs to patients' unique makeup. Becker C Mod Healthc; 2000 Aug; 30(36):24-8, 30, 33. PubMed ID: 11186365 [TBL] [Abstract][Full Text] [Related]
10. 'The future of cancer treatment'. O'Keefe B Fortune; 2001 Jul; 144(2):80. PubMed ID: 11471358 [No Abstract] [Full Text] [Related]
11. The intersection of biotechnology and pharmacogenomics: health policy implications. Phillips KA Health Aff (Millwood); 2006; 25(5):1271-80. PubMed ID: 16966723 [TBL] [Abstract][Full Text] [Related]
14. Is there a market for personal medicine? Sherrid P US News World Rep; 2003 Jan; 134(2):56. PubMed ID: 12561698 [No Abstract] [Full Text] [Related]
15. Developmental biology's impact on drug development. Cohen CM; Platika D; Scangos G; Kilian P Nat Biotechnol; 1998 Jul; 16(7):628-31. PubMed ID: 9661194 [No Abstract] [Full Text] [Related]
16. Jonathan K. C. Knowles discusses the impact of pharmacogenomics on market segmentation. Knowles JK Nat Rev Drug Discov; 2004 Oct; 3(10):822. PubMed ID: 15497246 [No Abstract] [Full Text] [Related]
17. R&D deals boom in 2004. Lawrence S Nat Biotechnol; 2005 Sep; 23(9):1036. PubMed ID: 16151383 [No Abstract] [Full Text] [Related]
18. Planning for a national effort to enable and accelerate discoveries in pharmacogenetics: the NIH Pharmacogenetics Research Network. Long RM Clin Pharmacol Ther; 2007 Mar; 81(3):450-4. PubMed ID: 17339874 [TBL] [Abstract][Full Text] [Related]
19. Evaluating the value of genomic diagnostics: implications for clinical practice and public policy. Issa AM Adv Health Econ Health Serv Res; 2008; 19():191-206. PubMed ID: 19548519 [TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics: questions and concerns. Mahlknecht U; Voelter-Mahlknecht S Curr Med Res Opin; 2005 Jul; 21(7):1041-7. PubMed ID: 16004671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]